Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Caterpillar Group President Anthony D. Fassino sold 10,671 shares on February 2, 2026, for about $7.2 million and exercised options to buy 15,000 shares at $196.70. Following the transactions he directly holds 41,151 shares and indirectly owns 1,499 shares via a 401(k). Separately, Caterpillar reported Q4 2025 earnings and revenue ahead of expectat…
Murray Stahl, President and Co-Portfolio Manager of RENN Fund, Inc. (RCG), purchased 954 shares on February 2, 2026, at $2.75 per share, a transaction valued at $3,118. The purchase occurred slightly above the fund's prevailing market price of $2.68. RENN Fund is a small-cap vehicle with a market capitalization of $18.78 million and nearly 37% reve…
Agilysys INC director Melvin L. Keating bought a total of 650 shares in two transactions on January 30 and February 3, 2026, spending $50,378 at prices between $81.90 and $84.84. After these purchases Keating directly holds 35,007 shares. Separately, Agilysys reported Q3 2026 revenue of $80.4 million, beating the $79.07 million estimate, while dilu…
Sun Country Airlines Holdings' senior commercial executive Colton Matthew Snow sold 752 shares on February 2, 2026, to satisfy tax withholding tied to vested restricted stock units. The transaction left Snow with 33,175 shares. The company is advancing a merger with Allegiant Travel Company that will pay Sun Country shareholders $4.10 in cash plus …
Thomas Buonaiuto, senior executive vice president at Flushing Financial Corp (NASDAQ: FFIC), sold 2,881 shares of company stock in two transactions totaling $45,977. The sales come amid a pending all-stock merger between Flushing Financial and OceanFirst Financial Corp valued at roughly $579 million and expected to close in the first half of 2026, …
Retired First Bancorp director Mary Clara Capel sold 2,642 shares of the bank's common stock on January 30, 2026, for $57.747 per share, a transaction totaling $152,567. The sale, reported on an SEC Form 4, left Capel with direct ownership of 25,399.6201 shares. Separately, First Bancorp posted earnings above expectations, benefited from a reserve …
Eagle Financial Services director Scott M Hamberger purchased 597 shares of the company at $37.99 apiece on January 30, 2026, a transaction totaling $22,680. After the buy, Hamberger directly holds 1,635.722 shares, which include shares obtained via the firm’s Dividend Investment Plan, and indirectly controls 10,064 shares through a revocable livin…
Hot GFG LLC sold 1,794,766 shares of Fat Brands, Inc. Class A common stock on January 30, 2026, receiving $485,843 in proceeds. After the transaction the holder no longer retains any Class A shares but continues to own 1,544,623 shares of Series B Cumulative Preferred Stock. The sale occurred as Fat Brands' stock has plunged 94.7% over the past yea…
Serina Therapeutics Chief Scientific Officer Randall Moreadith sold 6,500 shares on February 2, 2026, for $19,680 and simultaneously exercised 6,500 fully vested options at $0.06 per share. The company secured FDA clearance to begin a Phase 1b study of SER-252 and has started site activities in Australia, while facing a New York Stock Exchange noti…
Vicki L. Sato, a director at Vir Biotechnology, sold 22,000 shares on February 2, 2026, for $169,670 under a Rule 10b5-1 plan. The sale came as Vir shares have risen strongly year-to-date and over the past six months. The company recently reported encouraging Phase 2 SOLSTICE results for hepatitis delta therapy and struck a licensing agreement with…
Horizon Kinetics Asset Management LLC purchased one share of Texas Pacific Land Corp (NYSE: TPL) on February 2, 2026 at $338.12, leaving the firm with 3,479,364 shares. Texas Pacific Land's third-quarter 2025 results missed analyst expectations on both EPS and revenue. The company also announced a strategic tie-up with Bolt Data & Energy to develop…
Renasant Corporation's executive vice president and general counsel sold 6,000 shares of the company's common stock on February 2, 2026, for $37.8798 per share, generating $227,278 in proceeds. After the sale, the executive holds 65,172 shares. Separately, Renasant reported fourth-quarter 2025 adjusted EPS of $0.91 on revenue of $278.52 million, bo…
Robert Kenneth Mustard, a director at SR Bancorp, Inc. (NASDAQ: SRBK), bought 250 shares on February 2, 2026, at $17.05 per share, representing a $4,262 purchase. The filing shows Mustard now directly holds 1,250 shares. The transaction was executed under a power of attorney by William P. Taylor on February 3, 2026. Separately, SR Bancorp declared …
Scott G. Orzehoski, QNB CORP's Executive Vice President and Chief Lending Officer, sold 300 shares on January 30, 2026, and on the same day exercised stock options. The transactions occurred while QNB shares traded near a 52-week high; the bank also announced a quarterly cash dividend payable December 26, 2025.
Nucor Corporation Executive Vice President Needham Daniel R. disclosed the sale of 3,881 shares on January 30, 2026, in a Form 4 filing with the Securities and Exchange Commission. The shares were sold at $178.0 each, totaling $690818. After the trade, Needham directly holds 88298.37 shares. Separately, Nucor reported fourth-quarter 2025 results th…
Univest Financial director Natalye Paquin bought 580 shares on February 2, 2026, at $34.579 per share, totaling $20,055. Paquin also received 1,766 shares on January 31, 2026, following the vesting of restricted stock units, and holds 1,283 RSUs scheduled to vest on January 31, 2028. Separately, Univest reported stronger-than-expected fourth-quarte…
Robert Clark Nickles Jr., a director at First Financial Bankshares (FFIN), purchased 629 shares on February 2, 2026, for $20,467 through an indirect limited liability company. The bank also promoted James Alexander to Executive Vice President and Head of Commercial Banking as part of its succession planning. InvestingPro metrics cited in the filing…
Venu Holding Corp's CEO and chairman, Jay W. Roth, purchased 5,000 shares of the company's common stock on January 30, 2026, for $27,750. The company has released preliminary fourth-quarter revenue guidance, reported a large increase in total assets through 2025 and withdrew a proposed $75 million public stock offering due to unfavorable market con…
First Community Corp director Reynolds E. Leland bought 500 shares of the company's common stock on February 2, 2026, investing $14,834. After the purchase he owns 30,930 shares including deferred stock units. The bank posted $19.2 million in net income for 2025 and completed its acquisition of Signature Bank of Georgia on January 8, 2026.
Crane Co director Sanjay Kapoor reported a purchase of 2,814 shares on January 29, 2026, at $177.68 per share for a total of $499,991, according to a Form 4 filing. Separately, Crane Co's Q4 2025 results showed earnings per share of $1.53, in line with forecasts, while revenue came in at $581 million versus an expected $624.82 million, a shortfall …
Director Jennifer Pollino purchased 1,500 shares of Crane Co on January 29, 2026, spending $276,435 at $184.29 per share. The transaction comes as Crane Co reported fourth-quarter 2025 results with earnings per share matching forecasts at $1.53, while revenue of $581 million fell short of the $624.82 million analysts had expected. The earnings rele…
Kevin Hochman, president and CEO of Brinker International, sold 66,000 shares on January 29, 2026, for a total of $10,580,460 under a Rule 10b5-1 plan. He also gifted 2,000 shares the following day. Together, these moves leave him with 129,824 direct shares. Separately, Brinker reported fiscal 2026 second-quarter adjusted diluted EPS of $2.87 and r…
Marshall Urist, Executive Vice President, Research & Investments at Royalty Pharma PLC (NASDAQ:RPRX), sold 20,000 Class A Ordinary Shares on January 30, 2026, for about $821,810 under a pre-arranged 10b5-1 trading plan. Royalty Pharma reported a record $10 billion in the 2025 royalty funding market, completed its acquisition of PTC Therapeutics’ re…
Lindblad Expeditions insider Sven-Olof sold 183,639 shares across two days for roughly $3.07 million under a Rule 10b5-1 plan. The disposals leave him with 11,172,779 shares. The transactions come after the company reported third-quarter 2025 revenue ahead of expectations but an earnings-per-share shortfall, and announced a mandatory conversion of …
Adrian W. Quartel, Chief Medical Officer of Zevra Therapeutics (ZVRA), sold 4,533 shares on January 30, 2026, for about $40,035 at a weighted average price of $8.8321. The transactions recorded on a Form 4 also show the grant of restricted stock units and options and the exercise of options to acquire additional shares. Zevra's stock trades above t…
